Nigerian Pharma tycoon Stella Okoli raises $19.8 million to complete new production facility
Stella Okoli's Emzor has raised N26.7bn ($19.8m) at a 19% coupon to finish West Africa's first antimalarial API plant a Sagamu facility that was due to open in late 2025, then early 2026, and is still incomplete.